rs886039776
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_138927.4(SON):c.4640del(p.His1547LeufsTer76) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
SON
NM_138927.4 frameshift
NM_138927.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.555
Genes affected
SON (HGNC:11183): (SON DNA and RNA binding protein) This gene encodes a protein that contains multiple simple repeats. The encoded protein binds RNA and promotes pre-mRNA splicing, particularly of transcripts with poor splice sites. The protein also recognizes a specific DNA sequence found in the human hepatitis B virus (HBV) and represses HBV core promoter activity. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 21-33553870-CA-C is Pathogenic according to our data. Variant chr21-33553870-CA-C is described in ClinVar as [Pathogenic]. Clinvar id is 265776.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr21-33553870-CA-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SON | NM_138927.4 | c.4640del | p.His1547LeufsTer76 | frameshift_variant | 3/12 | ENST00000356577.10 | NP_620305.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SON | ENST00000356577.10 | c.4640del | p.His1547LeufsTer76 | frameshift_variant | 3/12 | 1 | NM_138927.4 | ENSP00000348984 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 39
GnomAD4 exome
Cov.:
39
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
ZTTK syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 02, 2016 | - - |
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | Sep 01, 2016 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 19, 2018 | The c.4640delA variant in the SON gene has been reported previously using alternate nomenclature c.4640del in the apparently de novo state in association with a SON-related disorder (Kim et al., 2016). The c.4640delA variant causes a frameshift starting with codon Histidine 1547, changes this amino acid to a Leucine residue, and creates a premature Stop codon at position 76 of the new reading frame, denoted p.His1547LeufsX76. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.4640delA variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.4640delA as a pathogenic variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at